SE9700983D0 - Stimulering, odling och preservation av pankreas- och andra celler - Google Patents

Stimulering, odling och preservation av pankreas- och andra celler

Info

Publication number
SE9700983D0
SE9700983D0 SE9700983A SE9700983A SE9700983D0 SE 9700983 D0 SE9700983 D0 SE 9700983D0 SE 9700983 A SE9700983 A SE 9700983A SE 9700983 A SE9700983 A SE 9700983A SE 9700983 D0 SE9700983 D0 SE 9700983D0
Authority
SE
Sweden
Prior art keywords
cells
cellulose derivative
stimulation
pancreatic
culture
Prior art date
Application number
SE9700983A
Other languages
English (en)
Inventor
Per Maansson
Tomas Lundin
Original Assignee
Ascendia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascendia Ab filed Critical Ascendia Ab
Priority to SE9700983A priority Critical patent/SE9700983D0/sv
Publication of SE9700983D0 publication Critical patent/SE9700983D0/sv
Priority to US09/381,650 priority patent/US6479283B1/en
Priority to CA002283676A priority patent/CA2283676C/en
Priority to DE69839393T priority patent/DE69839393T2/de
Priority to PCT/SE1998/000475 priority patent/WO1998041617A1/en
Priority to EP98909956A priority patent/EP0975739B1/en
Priority to JP54043798A priority patent/JP4237265B2/ja
Priority to AT98909956T priority patent/ATE393214T1/de
Priority to AU64313/98A priority patent/AU6431398A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SE9700983A 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler SE9700983D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler
US09/381,650 US6479283B1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic cells
CA002283676A CA2283676C (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
DE69839393T DE69839393T2 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
PCT/SE1998/000475 WO1998041617A1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
EP98909956A EP0975739B1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
JP54043798A JP4237265B2 (ja) 1997-03-18 1998-03-16 膵臓およびその他の細胞の刺激、培養および保存
AT98909956T ATE393214T1 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
AU64313/98A AU6431398A (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Publications (1)

Publication Number Publication Date
SE9700983D0 true SE9700983D0 (sv) 1997-03-18

Family

ID=20406207

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Country Status (9)

Country Link
US (1) US6479283B1 (sv)
EP (1) EP0975739B1 (sv)
JP (1) JP4237265B2 (sv)
AT (1) ATE393214T1 (sv)
AU (1) AU6431398A (sv)
CA (1) CA2283676C (sv)
DE (1) DE69839393T2 (sv)
SE (1) SE9700983D0 (sv)
WO (1) WO1998041617A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303586B1 (en) * 2000-06-28 2006-01-04 Ascendia AB Dna/rna-embedding medium and method of use
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20110071107A1 (en) * 2006-10-20 2011-03-24 Stephanie K Lynch Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
JP5714896B2 (ja) * 2007-05-04 2015-05-07 アセンディア アーベー 骨芽細胞の培養方法及び手段
WO2009111022A1 (en) * 2008-03-07 2009-09-11 Corning Incorporated Hydrophobically modified cellulose ether derivatives for cell culture and release
CN102573860A (zh) 2009-10-02 2012-07-11 巴克斯特国际公司 用于治疗肾脏损伤的造血干细胞
AU2012272586B2 (en) 2011-06-23 2016-07-07 The Children's Hospital Of Philadelphia Self-renewing endodermal progenitor lines generated from human pluripotent stem cells and methods of use thereof
JP2015508101A (ja) 2012-02-21 2015-03-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｃｄ３４＋細胞を含む薬学的組成物
EP3167911A1 (en) * 2015-11-10 2017-05-17 Oniris Si-hpmc-encapsulated insulin-producing cells for the treatment of type 1 diabetes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038139A (en) * 1976-07-16 1977-07-26 G. D. Searle & Co., Limited Cell culture medium
US4104124A (en) * 1976-08-30 1978-08-01 Louisiana State University Foundation Process for the production of single cell protein and amino acids
DE2726313C3 (de) * 1977-06-10 1980-02-07 Battelle-Institut E.V., 6000 Frankfurt Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin
US4330622A (en) * 1979-09-12 1982-05-18 Becton Dickinson & Co. Elimination of non-microbial turbidity in culture media
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
DD282471A5 (de) * 1989-04-21 1990-09-12 Staatliches Inst Fuer Immunpra Verfahren zur kultivation von mikroorganismen
JPH03175973A (ja) * 1989-09-26 1991-07-31 Kirin Brewery Co Ltd 動物細胞培養用担体およびその製造法
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5834308A (en) * 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo

Also Published As

Publication number Publication date
CA2283676A1 (en) 1998-09-24
CA2283676C (en) 2004-11-02
JP4237265B2 (ja) 2009-03-11
AU6431398A (en) 1998-10-12
DE69839393T2 (de) 2009-06-04
EP0975739B1 (en) 2008-04-23
JP2001521377A (ja) 2001-11-06
DE69839393D1 (de) 2008-06-05
US6479283B1 (en) 2002-11-12
ATE393214T1 (de) 2008-05-15
WO1998041617A1 (en) 1998-09-24
EP0975739A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
Axelrod et al. Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture
Lupton et al. Long-term effects of fermentable fibers on rat colonic pH and epithelial cell cycle
ATE204176T1 (de) Verwendung von insulinähnlichen wachstumsfaktoren und analogen zur behandlung von erkrankungen der sehnerven
DE69801517D1 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
SE9700983D0 (sv) Stimulering, odling och preservation av pankreas- och andra celler
PL322015A1 (en) Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them
DE69637730D1 (de) Verfahren zur in vito vorbehandlung von myoblasten vor deren transplantation
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
MX7708E (es) Procedimiento mejorado para estimular el crecimiento de plantas
ATE5854T1 (de) Zusammensetzungen zur verwendung bei der verminderung des appetites auf kohlenhydratkalorien.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
Sato et al. Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver
DK230590D0 (da) Sproejte til brug ved kataraktkirurgi
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
Gainer et al. Neuromuscular junctions in a fast-contracting fish muscle
IT8422049A0 (it) Dispersioni stabili di polimeri organici in poliepossidi eprocedimento per preparare tali dispersioni.
ATE254884T1 (de) Biologisch abbaubare vorrichtung
ES2170961T3 (es) Medios artificiales para criar entomofagos.
DK1056467T3 (da) Metode til behandling af sygdomme eller lidelser i det indre øre
CA2225898A1 (en) Enhancing keratinocyte migration and proliferation
DE69902397T2 (de) Neues verfahren zur kryokonservierung von pflanzen
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
GR1001093B (el) Απορροφητικό υλικό, μέ?οδος επίτευξης απορροφητικού υλικού, απορροφητικό υπό?εμα, μέ?οδος επίτευξης απορροφητικού υπο?έματος, και απορροφητικό αντικείμενο μιας χρήσεως.
FI930654A0 (fi) Loesligt aldc-derivat och anvaendning av detta
DE3785895D1 (de) Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.